Norbert G Riedel Cerevel Therapeutics Holdings, Inc. (CERE) insider trading activity

CERE Quotes by TradingView

Norbert G Riedel is of Cerevel Therapeutics Holdings, Inc.. Currently has a direct ownership of 0 shares of CERE, which is worth approximately $0. The most recent transaction as insider was on Aug 01, 2024, when has been sold 56,553 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 0
0% 3M change
100.0% 12M change
Total Value Held $0

NORBERT G RIEDEL Transaction History

Date Transaction Value Shares Traded Shares Held Form
Aug 01 2024
SELL
Sale (or disposition) back to the issuer
-
56,553 Reduced 100.0%
0 Common Stock
Jun 05 2024
BUY
Grant, award, or other acquisition
-
10,461 Added 15.61%
56,553 Common Stock
Jun 07 2023
BUY
Grant, award, or other acquisition
-
3,282 Added 6.65%
46,092 Common Stock
Jan 04 2022
BUY
Exercise of conversion of derivative security
-
14,270 Added 25.0%
42,810 Common Stock
Jan 04 2021
BUY
Exercise of conversion of derivative security
-
14,270 Added 33.33%
28,540 Common Stock

Also insider at

APTX
Aptinyx Inc. Healthcare
EXECUTIVE CHAIRMAN OF THE BOD
ETON
Eton Pharmaceuticals, Inc. Healthcare
Director
JAZZ
Jazz Pharmaceuticals plc Healthcare
Director
NGR

Norbert G Riedel

Dublin 4, L2

Track Institutional and Insider Activities on CERE

Follow Cerevel Therapeutics Holdings, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells CERE shares.

Notify only if

Insider Trading

Get notified when an Cerevel Therapeutics Holdings, Inc. insider buys or sells CERE shares.

Notify only if

News

Receive news related to Cerevel Therapeutics Holdings, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on CERE